Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

NCT01164384 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT01164384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01164384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.
Lead sponsor
University of Zurich
Phase
Phase 1
Overall status
Unknown status
Start date
October 31, 2010
Completion date
February 28, 2013
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hcv hepatitis c